Posts in tag
musculoskeletal disorders
S3 celecoxib: expanding pharmacists’ options for managing musculoskeletal pain
The recent decision by the Therapeutic Goods Administration to include celecoxib 200mg as the first Schedule 3 (Pharmacist Only Medicine) selective COX-2 inhibitor in a primary pack containing not more …
Rheumatoid arthritis
This article aims to assist pharmacists counsel their patients living with rheumatoid arthritis in all settings to understand their therapeutic goals, the options available and to manage their condition, and …
Musculoskeletal health: MSK survey helps make the invisible visible
Many people are experiencing pain seven days a week affecting their ability to work and function, a musculoskeletal health survey finds.1 Living with a musculoskeletal condition is negatively effecting the …